MiMedx Group, Inc. (MDXG) shares surged 14.87% in pre-market trading on Thursday, following a bullish analyst move. The significant uptick comes as investors react positively to an increased price target from a prominent Wall Street firm.

Cantor Fitzgerald, a well-respected financial services company, raised its price target on MiMedx to $12 from $11, while maintaining an Overweight rating on the stock. This adjustment represents a vote of confidence in the company's future prospects and suggests potential upside from its current trading levels.

The raised price target and maintained Overweight rating could signal to investors that MiMedx Group has strong growth potential, possibly driven by positive developments in its business operations or market conditions. As pre-market trading often sets the tone for the regular session, this early surge may indicate continued investor interest throughout the day.